Implantable cardioverter defibrillators and Chagas' disease: Results of the ICD Registry Latin America

Europace

Volumn 11, Issue 2, 2009, Pages 164-168

  Muratore, Claudio A ^a,f   Batista Sa, Luiz A ^b   Chiale, Pablo A ^c   Eloy, Ricardo ^d   Tentori, Maria Cristina ^a   Escudero, Jaime ^e   Lima, Antonio Malan Cavalcanti ^f   Medina, Luis E ^g   Garillo, Raúl ^h,i   Maloney, Jennifer ^h,i  

^a HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^b Hospital Monte Sinai   (Brazil)

^c HOSPITAL RAMOS MEJÍA   (Argentina)

^d HOSPITAL SANTA IZABEL   (Brazil)

^e Hospital de Clinicas Caracas   (Venezuela)

^f Santa Casa de Goiania ^*  (Argentina)

^g Clinica Medellin   (Colombia)

^h Medtronic Latin America   (Argentina)

ⁱ MEDTRONIC INC   (United States)

Author keywords

Chagas' disease; Defibrillators; ICD; Sudden death; Ventricular arrhythmias

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROPAFENONE;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHAGAS DISEASE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SOUTH AND CENTRAL AMERICA; SUDDEN DEATH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARRHYTHMIAS, CARDIAC; CHAGAS CARDIOMYOPATHY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 59449096706     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun325     Document Type: Article

References (24)

1. World Health Organization. Control of Chagas' disease. Report of a WHO Expert Committee. Technical Report Series 811, Geneva, 1991.
2. Dias E, Laranja FS, Miranda A, Nobrega G. Chagas' disease: a clinical, epidemiologic and pathologic study. Circulation 1956;14:1035-60.
3. Mota EA, Guimaraes AC, Santana OO, Sherlock I, Hoff R, Weller TH. A nine year prospective study of Chagas' disease in a defined rural population in northeast Brazil. Am J Trop Med Hyg 1990;42:429-40.
4. Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol 2001;76:75-96.
5. Aras R, de Matta JA, Mota G, Gomes I, Melo A. Cerebral infarction in autopsies of chagasic patients with heart failure. Arq Bras Cardiol 2003;8:411-3.
6. Baranchuk A, Rosas F, Morillo CA. Enfermedad de Chagas en Países Desarrollados: Mito o Realidad (Chagas' disease in developed countries: myth or reality). In Rosas F, Vanegas D, Cabrales M eds. Enfermedad de Chagas, Bogotá, Sociedad Colombiana de Cardiología, Sociedad Española de Cardiologia; 2007. p217-9.
7. The Antiarrhythmics Versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
8. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.
9. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmia drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.
10. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
11. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
12. Muratore C, Rabinovich R, Iglesias R, Gonzalez M, Darú V, Sosa Liprandi A. Implantable cardioverter defibrillators in patients with Chagas disease: are they different from patients with coronary disease? Pacing Clin Electrophysiol 1997;20:194-7.
13. Cardinalli-Neto A, Greco O, Bestetti R. Automatic implantable cardioverter-defibrillators in Chagas heart disease patients with malignant ventricular arrhythmias. Pacing Clin Electrophysiol 2006;29:467- 70.
14. Cardinalli-Neto A, Bestetti R, Cordeiro J, Rodrigues V. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 2007;18:1236-40.
15. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter- defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998;32:1909-15.
16. Rabinovich R, Muratore C, Iglesias R, Gonzalez M, Daru V, Valentino M et al. Time to first shock in implantable cardioverter defibrillator (ICD) patients with Chagas cardiomyopathy. Pacing Clin Electrophysiol 1999;22:202-5.
17. Bargaza FJ, Clavijo PC, Sanchez MD, Hevia JC, Molina RZ, Perez MA et al. Electrical storm in patients with implantable cardioverter- defibrillator. Arch Cardiol Mex 2008;78:68-78.
18. Devecchi P, Plebani L, Occhetta E, Bortnik M, Francalacci G, Magnani A et al. Electrical storms in patients with implantable cardioverter-defibrillator: incidence and clinical management. G Ital Cardiol 2006;7:695-701.
19. Molina RB, Matsubara BB, Hueb JC, Zanati SG, Meira DA, Cassolato JL et al. Dysautonomia and ventricular dysfunction in the indeterminate form of Chagas disease. Int J Cardiol 2006;113:188-93.
20. Ribeiro AL, Moraes RS, Ribeiro JP, Ferlin EL, Torres RM, Oliveira E et al. Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. Am Heart J 2001;141:260-5.
21. Link MS, Wang PJ, Haugh CJ, Homoud MK, Foote CB, Costeas XB et al. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillator. J Intervent Card Electrophysiol 1997;1:41-8.
22. Tavernier R, Gevaert S, De Sutter J, De Clercq A, Rottiers H, Jordaens L et al. Long term results of cardioverter defibrillator in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 2001;85:53-6.
23. Silva RM, Tavora MZ, Gondin FA, Metha N, Hara VM, de Paola AA. Predictive value of clinical and electrophysiological variables in patients with chronic chagasic cardiomyopathy and nonsustained ventricular tachycardia. Arq Bras Cardiol 2000;75:33-47.
24. Rassi A Jr. Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial. J Cardiovasc Electrophysiol 2007;18:1241-3.